These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8823501)

  • 21. [Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
    Shinozawa S; Gomita Y; Araki Y
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):805-9. PubMed ID: 1605657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
    Belpaire FM; Bogaert MG; Rosseneu M
    Eur J Clin Pharmacol; 1982; 22(3):253-6. PubMed ID: 6125395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple human serum binding of two thienopyridinic derivatives, ticlopidine and PCR 2362, and their distribution between HSA, alpha1-acid glycoprotein and lipoproteins.
    Glasson S; Zini R; Tillement JP
    Biochem Pharmacol; 1982 Mar; 31(5):831-5. PubMed ID: 7082352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of minaprine to human serum proteins and erythrocytes.
    Barré J; Houin G; Jeanniot JP; Coirre C; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(1):1-9. PubMed ID: 3957500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective plasma protein binding of amlodipine.
    Maddi S; Yamsani MR; Seeling A; Scriba GK
    Chirality; 2010 Feb; 22(2):262-6. PubMed ID: 19496159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein binding and stability of norepinephrine in human blood plasma. Involvement of prealbumin, alpha 1-acid glycoprotein and albumin.
    de Vera N; Cristófol RM; Rodríguez Farré E
    Life Sci; 1988; 43(16):1277-86. PubMed ID: 3172980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective drug-protein interaction between mexiletine and plasma protein.
    Yu L; Hong Y; Li L; Jin Y; Zheng M; Jiang H; Zeng S
    J Pharm Pharmacol; 2012 Jun; 64(6):792-801. PubMed ID: 22571257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration.
    Demant EJ; Friche E
    Biochem Pharmacol; 1998 Jan; 55(1):27-32. PubMed ID: 9413926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of chlorpheniramine enantiomers to human plasma proteins.
    Hiep BT; Gimenez F; Khanh VU; Hung NK; Thuillier A; Farinotti R; Fernandez C
    Chirality; 1999; 11(5-6):501-4. PubMed ID: 10368923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
    Pike E; Kierulf P; Skuterud B; Bredesen JE; Lunde PK
    Br J Clin Pharmacol; 1983 Sep; 16(3):233-9. PubMed ID: 6626414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
    Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPLC assay for atropine in serum and protein solutions after in vitro addition of the tropane alkaloid.
    Büch U; Isenberg E; Büch HP
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):361-5. PubMed ID: 7934315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.